Introduction. Trypanosoma cruzi is as potentially destructive to human beings as is a nuclear bomb, yet it is so minuscule that it largely goes unnoticed

Trypanosoma cruzi is as potentially destructive to human beings as is a nuclear bomb, yet it is so minuscule that it largely goes unnoticed. Trypanosoma cruzi (T. cruzi) causes what is known as American trypanosomiasis, or Chagas’ disease. The first time that I saw T. cruzi was June 6, 1991, in Cochabamba, Bolivia. I recorded the following notes:

Yesterday, I saw T. cruzi under the electronic microscope. They clustered together, like strands of tangled wool, and were wiggling violently, like so many minuscule hydra monsters, trying to break free with their tentacles and attack you. One broke free and swam toward me…

Hernan Bermudez, laboratory technician, then looked into the microscope and exclaimed “El Asesino!” [“The Assassin!”]. I felt thrilled to be face to face with the parasite that was infecting millions of people in Latin America, that has spread so rapidly throughout Latin America, and that can multiply to millions of offspring in the human body.

The sighting of T. cruzi did not generate hatred but awe and respect. It began a lasting relationship.

T. cruzi infects 18 million people in Latin America and is the major public health problem for development in Latin America, because it debilitates and kills adults during their prime of life (World Health Organization 1985, 1991, 1994, 1996). The Pan American Health Organization has identified Chagas’ disease as the most important parasitic disease in Latin America and the major cause of myocardial illness (PAHO 1984). This flagellate protozoan parasite travels to humans through the bite of triatomine bugs–a particular order of sucking insects–entering neuron tissues of the heart and other organs and causing irreversible cardiac and gastrointestinal tract lesions in 30 to 40 percent of the cases. T. cruzi migrates by means of infected bugs, animals, humans, blood transfusions, and organ transplants. Currently, there is no cure for the chronic stage of Chagas’ disease, but T. cruzi can be controlled through improved housing and hygiene. Named after Carlos Chagas, who discovered T. cruzi in Brazil in 1909, Chagas’ disease has spread throughout Latin America and the Southwestern United States (see Figure 1).

^{Figure 1.}

^{Geographic distribution of Chagas’ disease in Latin America. Although it is still difficult to form an accurate picture of the geographic distribution and prevalence of Chagas’ disease, among an estimated total population in the endemic countries of 360 million people (excluding Mexico and Nicaragua, for which adequate data are not available), at least 90 million persons (25 percent) are at risk of infection, and from 16 to 18 million people are infected. (World Health Organization 1991:27). (See Appendices 6 and 7.)}

This book concerns Chagas’ disease in Bolivia, where infection rates are higher than in any other Latin American country (SOH/CCH 1994). It shows how human beings have created environmental and social contexts for the spread of Chagas’ disease and addresses such questions as these: Can humans be as effective in eliminating such diseases as they are in promulgating them? What are successful prevention projects and what are not? What factors are necessary to design a successful intervention project? Further, it shows how Andeans have culturally adapted to the spread of the disease and illustrates why understanding cultural belief systems is critical to the success of prevention programs.

Surprisingly, many Bolivians are unaware of Chagas’ disease and rarely suspect it as the cause of death. They attribute its symptoms to other causes such as heart disease, volvulus, improper foods, and fatigue. While it is unnecessary that most individuals understand Chagas’ disease from a biomedical perspective, health educators need to translate scientific information about the disease into culturally appropriate categories that are sensitive to indigenous values, traditions, and motivations. To do this, health educators need to integrate the biomedical knowledge of Chagas’ disease with the ethnomedical practices of Andeans.

Chagas’ disease has received little attention and funding of research, treatment, and prevention measures, perhaps because of who gets itpoor, illiterate, indigenous Andean peasants. This lack of attention is also a result of the disease’s latent periods in the human body (see Figure 8). Frequently, T. cruzi lies dormant for years until manifesting itself in the critically debilitating chronic state. Peasants seldom connect bites from vinchuca bugs to heart disease, so the disease spread by the bite goes undetected at early, treatable stages.

Chagas’ latent states and mobility relate it to other slow‑acting killersother epidemics and diseases that cross boundaries. Infected insects, humans, and animals allow T. cruzi to travel swiftly and to enter homes unannounced to its hosts. In this, Chagas’ disease shares certain features with other diseases, such as AIDS. It is environmentally driven, as is AIDS. Similar “new” diseases have emerged from the savannas of eastern Bolivia (Hemorrhagic Fever), the rainforests of northern Zaire (Ebola virus), a Navajo reservation in the Four Corners region of the western United States (Hantavirus), and the urban poverty of the south Bronx (see Garret 1994). Yet, Chagas’ disease is ancient. In this case, it is a parasitic disease encouraged by environmental changes that bring T. cruzi, vinchucas, and humans into close contact. Humans destroy natural animal hosts for this parasite and habitats for its vector bug. As a result, parasite and vector have moved to humans. Parallels also can be found with Lyme disease. Suburban housing developments encroach on forest areas where humans come into contact with rodents, especially white‑footed deer mice. These rodents host Ixodid ticks, vectors of Borrelia burgdorferi, a spirochete that causes Lyme disease (see Spielman et al. 1985; Burgdorfer et al. 1985).

Our awakening to these disease agents is a challenge of the coming millennium. To catch a glimpse of diseases to come, this book details an epidemic battle in Bolivia, a seemingly remote country, and shows how to win it. It provides suggestions for community members, health workers, and social scientists on how to stop Chagas’ disease. It is also important to examine factors of the disease’s spread in Bolivia to prevent this from happening elsewhere.

Andeans have excellent ways of dealing with native diseases, but they also need anthropologists with cultural sensitivity and doctors with biomedical expertise to help them adapt to potential epidemics. These epidemics are in part phenomena of the late twentieth century. They are aided by overpopulation, massive migrations, urbanization, widespread impoverishment, destruction of the rainforests, and erosion of valuable soil, among other factors. Curtailing Chagas’ disease calls for public policy changes to stop the above practices, to increase research and international assistance, and to recognize and utilize indigenous medical systems in its control.

To what extent does a personal agenda interfere with objective research? It is difficult for medical anthropologists to espouse scientific positivism when they are studying traditional medical systems based on premises other than positivism, such as divination, spirits, balances, social relationships, and cultural continuity. Often there are no ways to prove why things work in a culture; the fact can only be noted that they do. Consequently, analyses and interpretations of medical anthropologists are personal and to some degree subjective.

What gives credibility to anthropologists’ interpretations is their fieldwork and their data. The following explains some of the reasons why I argue throughout this book for an understanding of Andean ethnomedicine and a culturally sensitive approach to Chagas’ control in Bolivia. This book results from thirty‑four years of experience, research, and fieldwork in Bolivia, beginning in 1963 when I first arrived as a Maryknoll priest and worked for six years among the Aymaras of the Altiplano (a plateau 12,500 feet high). I learned the Aymara and Spanish languages. After certain misgivings about missionization, I left the priesthood in 1969 and studied anthropology and the Quechua language at Cornell University to learn about Andean culture. In 1971 I married Judy Wagner and we returned to Bolivia to live with the Kallawaya people, only this time to participate in their rituals and to study how Andean religion has enabled these people to adapt to sickness. Their rituals were symbolic and spiritual processes of dealing with Western diseases (typhoid fever, septicemia, and heart disease) and cultural illnesses (chullpa usu, liquichado, cólico miserere), to name a few. This resulted in my first book, Mountain of the Condor: Metaphor and Ritual in an Andean Ayllu (Bastien 1978). I had become aware of the importance of Andean rituals in the society’s health maintenance and that the biology of disease is perceived differently by these people.

I next studied Kallawaya herbalists to learn about their uses of medicinal plants and how these could be used with biomedicine. Kallawayas employ about a thousand medicinal plants and are renowned throughout Argentina, Bolivia, Peru, and Chile as very skilled herbalists. This research resulted in Healers of the Andes: Kallawaya Herbalists and Their Medicinal Plants (Bastien 1987). I published an herbal manual in Spanish for peasants that was used for training community health workers in the Department of Oruro, Bolivia (Bastien 1983). I returned to Bolivia almost every year to do research.[1]

By 1980, I again felt the missionary’s impulse, not to evangelize but to argue for the inclusion of Andean traditional medicine, especially herbal medicines, rituals, and curanderos, into national and international health programs. I became an advisor to the National Secretariat of Health and the United States Agency of International Development on the integration of ethnomedicine and community health workers into primary health care programs.[2]

A more recent endeavor to integrate both types of medicine has been my collaborative research with chemists and pathologists in the testing of Kallawaya‑Bolivian medicinal plants for curing AIDS, cancer, Chagas’ disease, and tuberculosis. The results are significant, with certain plants being protease inhibitors for AIDS, and others curing cancer and tuberculosis (Bastien et al. 1990, 1994, 1996). Kallawaya plant medicines also show promise as cures for Chagas’ disease. Scientists at the University of Antofagasta, Chile, are examining these plants.

Bolivian and international health personnel are beginning to integrate ethnomedicine and biomedicine in Bolivia, as I discuss in Drum and Stethoscope: Integrating Ethnomedicine and Biomedicine in Bolivia (Bastien 1992). Doctors, nurses, and project workers work with shamans, midwives, and community health workers in joint clinics. Associations of community health workers, midwives, and herbalists negotiate with doctors and nurses. The National Secretariat of Health coordinates both types of medicine, including providing staffed positions in ethnomedicine. State‑run pharmacies stock and sell herbal medicines. This recognition and respect of Andean traditional medicine is encouraging; however, the current hegemony of biomedical medicine, propelled by pharmaceutical and insurance companies, medical associations, and privatization, essentially pits capitalist entrepreneurs against ethnic curanderos and shamans in what becomes for the latter a losing battle.

Kiss of Death’s call for activism is unusual in a scholarly text, but I feel it is appropriate if it helps lead to the creation of prevention programs. Western medical ethics has come to address the manner of distributing resources that affect the maintenance or restoration of health as a moral problem (see Lieban 1990:227). The pattern of allocating resources basic to health and survival raises serious ethical issues in light of the principle of distributive justice, defined as “the justified distribution of benefits and burdens in society” (Beauchamp and Childress 1983:184). Does distribution of resources for combatting Chagas’ disease involve a conflict between the perceived higher valuation of certain communities over others, males over females, adults over children, and wealthier countries over poorer countries?

Because Chagas’ control projects are expensive and involve only a small percentage of communities in Bolivia, an evaluation of their effectiveness as pilot projects is important. For this reason, I concentrate on two pilot projects in the Departments of Chuquisaca and Tarija. The Proyecto Británico‑Cardenal Mauer (PBCM) project in the Department of Chuquisaca was considered a successful Chagas’ control project in 1991 by the National Chagas’ Control Committee, which recommended it as a model for other projects throughout Bolivia. It provided a primary health care infrastructure into which Chagas’ control was included. Ruth Sensano organized this infrastructure. The Tarija project stands out for its education of the local populace about Chagas’ disease. José Beltran is the leading educator in this project. Sensano and Beltran are highlighted in these projects because they illustrate what individual Bolivians are doing. These projects serve to help create an improved model that reaches more people more economically and within the cultural context of the community.

I observed other projects, which were heavily funded, hastily done, and had limited effect on Chagas’ control. These projects concentrated on new houses and insecticides, measures that are not affordable and sustainable over time. Insecticides have become too expensive for most communities without government subsidies, which have been discontinued. The pilot nature of these projects failed because they never presented a model to follow. This book assesses the justice of the allocation of health resources in regard to Chagas’ disease. Moreover, it suggests alternative solutions to the problem of providing more people with the means to prevent Chagas’ disease.